Andrew Sinclair Soleno Therapeutics Inc (SLNO) insider trading activity

SLNO Quotes by TradingView

Andrew Sinclair is of SOLENO THERAPEUTICS INC. Currently has a direct ownership of 10,491 shares of SLNO, which is worth approximately $894,462. The most recent transaction as insider was on Jun 05, 2025, when has been sold 3,991 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.5K
61.4% 3M change
61.4% 12M change
Total Value Held $894,462

Andrew Sinclair Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 05 2025
BUY
Grant, award, or other acquisition
-
3,991 Added 27.56%
10,491 Common Stock
Jun 06 2024
BUY
Grant, award, or other acquisition
-
6,500 Added 50.0%
6,500 Common Stock

Also insider at

ACET
Adicet Bio, Inc. Healthcare
SRRA
Sierra Oncology, Inc. Healthcare
Director
VRNA
Verona Pharma plc Healthcare
Director
AS

Andrew Sinclair

Redwood City, CA

Track Institutional and Insider Activities on SLNO

Follow SOLENO THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SLNO shares.

Notify only if

Insider Trading

Get notified when an Soleno Therapeutics Inc insider buys or sells SLNO shares.

Notify only if

News

Receive news related to SOLENO THERAPEUTICS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SLNO